Late-Stage AMD is the Leading Cause of Blindness in Older Americans1
At Samsara Vision, our novel telescope technology combined with our patient support program provides health care providers with an important option to treat their most visually impaired patients living with late-stage AMD. We’re also invested in creating next-generation devices and delivery systems that will improve the surgical experience for both the provider and the patient. Our goal is to help the late-stage AMD patient population gain access to technology that is proven to improve their quality of life and extend the freedom they have to reengage in the activities that are most important to them.
Market Opportunity:
- A 2017 study published in JAMA Ophthalmology by Neely and colleagues revealed that a large number of AMD cases go undetected and undiagnosed in the primary eye care setting.2
- As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050.3
- A study published in The Lancet projects that the number of people worldwide with AMD will grow from 196 million in 2020 to 288 million in 2040.4 AMD is the leading cause of irreversible visual loss in the United States, with variable degrees of age-related macular changes occurring in more than 10% of the population aged 65-74 years and 25% of the population older than 74 years.5 6 7
